Back to Top
This subscription includes:
Tissue Engineering, Part A
Tissue Engineering, Part B: Reviews
Tissue Engineering, Part C: Methods

Aims & Scope


Tissue Engineering, Part A: Research Advances serves as the authoritative peer-reviewed biomedical journal advancing the field with cutting-edge hypothesis-driven research focused on tissue repair or regeneration. This multidisciplinary journal brings together the fundamental and applied principles of engineering and life sciences in the creation of artificial tissues and regenerative medicine. 


Tissue Engineering, Part A: Research Advances launched in 1994 and marks the first academic journal devoted to covering the field of tissue engineering. The journal has served as a central forum for groundbreaking scientific research and developments of clinical applications from leading experts in the field that will enable the functional replacement of tissues. The journal focuses specifically on the theoretical, computational, and experimental aspects for the development of therapeutic strategies to repair or regenerate tissue and organ function. 


The journal provides “instant online” publication of accepted articles within 72 hours of acceptance and publishes 12 double issues online and in print annually. The journal is Green Open Access compliant and supports various options for authors to publish their work under a CC-BY Open Access license. 

Complete coverage includes: 

  • Basic and clinical advances in tissue engineering and regenerative medicine
  • Novel approaches to regenerative medicine applying controlled/sustained release strategies
  • Surface modification technologies; protein adsorption and cell behavior
  • In vivo responses to cell-material constructs
  • Bioactive molecules and the development of carrier systems 
  • Bioreactors for 2D and 3D tissue growth
  • Applied nanotechnology and/or non-invasive imaging approaches
  • Inductive scaffolds and matrices 
  • Organoids, organs-on-a-chip, and smart systems
  • Self-assembly materials
  • Artificial Intelligence in tissue engineering and regenerative medicine
  • Cell therapy
  • Immunotherapy
  • Commercial development of tissue engineering and regenerative medicine products

Tissue Engineering Part A: Research Advances is under the editorial oversight and leadership of Co-Editors-in-Chief Antonios G. Mikos, PhD, Rice University, and John P. Fisher, PhD, Fischell Department of Bioengineering, University of Maryland. For pre-submission inquiries, please contact Managing Editor Olivia Mulder at teeditor@rice.edu.  

Audience: Biomedical and biomaterials engineers, biomaterials scientists, cell and molecular biologists, chemists, stem cell researchers, biochemists, biophysicists, wound care specialists, surgeons specializing in chronic and degenerative diseases, medical researchers, clinicians, and surgeons.

Indexing/Abstracting:

  • PubMed/MEDLINE
  • PubMed Central
  • Web of Science: Science Citation Index Expanded™ (SCIE)
  • Scopus
  • Current Contents®/Life Sciences
  • Biotechnology Citation Index®
  • Biological Abstracts
  • BIOSIS Citation Index™
  • Journal Citation Reports/Science Edition
  • EMBASE/Excerpta Medica
  • EMBiology
  • Compendex
  • Chemical Abstracts
  • ProQuest databases
  • BenchSci
The views, opinions, findings, conclusions and recommendations set forth in any Journal article are solely those of the authors of those articles and do not necessarily reflect the views, policy or position of the Journal, its Publisher, its editorial staff or any affiliated Societies and should not be attributed to any of them.

Society Affiliations

The Official Journal of: